China’s Mindray Medical Leads Retreat as Sales Disappoint

Chinese stocks listed in the U.S. declined for a second day as Mindray Medical International Ltd., a medical device maker, reported first-quarter revenue that trailed analyst estimates.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.